Dana-Farber Cancer Institute: Carcinoma, Non-Small-Cell Lung trials

The registry lists 17 Carcinoma, Non-Small-Cell Lung studies with Dana-Farber Cancer Institute as lead sponsor. 3 are open to participants now and 6 have results posted.

Phase 1 5Phase 2 12No phase 4(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Precise Exercise Regimen for Cancer Care (PERCC): A Pilot StudyRecruitingNCT07412041Not applicable
• Biology of Young Lung Cancer Study: The YOUNG LUNG StudyRecruitingNCT05265429
• Nano-SMART: Nanoparticles With MR Guided SBRT in Centrally Located Lung Tumors and Pancreatic CancerRecruitingNCT04789486Phase 1/2
• Biomarkers of Response to Ipilimumab and Nivolumab in First-line NSCLCTerminatedNCT03425331Phase 2Results posted
• A Study of Alectinib in RET-rearranged Non-small Cell Lung Cancer or RET-mutated Thyroid CancerTerminatedNCT03131206Phase 1/2Results posted
• Merestinib In Non-Small Cell Lung Cancer And Solid TumorsTerminatedNCT02920996Phase 2Results posted
• Rapid Plasma Genotyping For Early Initiation Of Erlotinib In EGFR Mutant Lung CancerTerminatedNCT02770014Phase 2Results posted
• Feasibility Study of Enhanced MRI for Early Stage Non Small Cell Lung Cancer (NSCLC)TerminatedNCT01799135Not applicableResults posted
• Stereotactic Boost for Locally Advanced Non-Small Cell Lung CancerTerminatedNCT01222572Phase 1/2Results posted
• Osimertinib In EGFR Mutant Lung CancerActive, not recruitingNCT03586453Phase 2
• A Phase 2 Study of Osimertinib in Combination With Selumetinib in EGFR Inhibitor naïve Advanced EGFR Mutant Lung CancerActive, not recruitingNCT03392246Phase 2
• Osimertinib and Gefitinib in EGFR Inhibitor naïve Advanced EGFR Mutant Lung CancerActive, not recruitingNCT03122717Phase 1/2
• Healthy Directions After Lung Surgery PilotCompletedNCT02135211Not applicable
• PALBOCICLIB + PD-0325901 for NSCLC & Solid TumorsCompletedNCT02022982Phase 1
• Bevacizumab and Carboplatin/Paclitaxel and Radiation in Non-Small Cell Lung CancerCompletedNCT00578149Phase 2
• Cetuximab and Vinorelbine in Elderly Subjects With Lung CancerCompletedNCT00165334Phase 2
• Study of OSI-774 (Tarceva) in Previously Untreated Elderly Lung Cancer PatientsCompletedNCT00137800Phase 2